Clinical Effect and Action Mechanism of Weicao Capsule(威草胶囊)In Treating Gout

Obiective:To study the therapeutic effect of Weicao Capsule(威草胶囊,WCC)on gout.Methods:Two hundred gout patients were assigned to two groups.The treated group was groups were given the respective treatments orally 3 times a day,2 capsules each time with 2 weeks as one course and all patients received 2 successive courses of treatment.Changes of blood β2-microglobulin(β2-M),hemoglobin(Hb),24 h urinary protein(24 h UP),pH value of urine and blood uric acid(BUA)as well as kidney function were observed.Results:After treatment,IeveI of β2-M got lowered significantly,Hb and 24 h UP,blood urea nitrogen,serum creatinine and the clearance rate of creatinine,as well as blood lipids all improved obviously in the treated group(all P＜0.01),while these parameters remained unchanged in the control group (P＞0.05).The pH value of urine was improved in both groups showing an insignificant difference between them(P＞0.05).BUA was decreased in both groups with a decrease to a larger extent in the treated group(P＜0.01).The total effective rate was 87% in the treated group,which was superior to that in the control group(62%,P＜0.05).Conclusion:WCC has a favorable therapeutic effect on gout and its mechanism of action for improving renal function and reducing urinary protein could be related with the lowering of blood β2-M,BUA and lipids.     

Clinical observation on the treatment of childhood refractory idiopathic thrombocytopenic purpura with Dihuang Zhixue Capsule (地黄止血胶囊)

Objective： To observe the clinical effect of Dihuang Zhixue Capsule （地黄止血胶囊, DZC, a Chinese preparation for cooling blood and dispelling toxic substances） in the treatment of childhood refractory idiopathic thrombocytopenic purpura （RITP）, with cyclosporin A （CsA） used as the control. Methods： Forty-one children of RITP were randomized into the treated group and the control group. The 21 patients in the treated group were orally given 2 to 3 DZC capsules each time, thrice a day and the 20 in the control group were given 3 mg/kg CsA per day, with 3 months as one therapeutic course. The therapeutic efficacy, platelet count and adverse reaction in the two groups were compared at the end of the course. Results： （1） In the treated group, 1 （4.8%） patient was evaluated as cured, 3 （14.3%） as markedly effective, 5 （23.8%） as effective, 5 （23.8%） as improved, 7 （33.3%） as ineffective, with the total effective rate being 66.7%; while in the control group, the corresponding numbers were 0. 2 （10.0%）, 2 （10.0%）, 3 （15.0%）, 13 （65.0%） and 35.0%, respectively, showing statistical significance in difference between the total effective rates of the two groups （ Х^2=4.11, P=0.0426）. （2） As compared with the baseline, the platelet count increased in both groups after 2 months＇ treatment （P〈0.05）. After 3 months＇ treatment, the platelet count was higher in the treated group than in the control group （P〈0.05）. （3） The improvement of hemorrhage in the treated group after 8 weeks＇ treatment was better than that in the control group （P〈0.05）. （4） No apparent adverse reaction was observed in the treated group, while in the control group, hirsutism was shown in 15 cases; gingival hyperplasia in 10; digestive reaction in 5, liver function impairment in 5, hypertension in 2 and renal impairment in 2. Conclusion： The therapeutic efficacy of DZC is better than that of CsA, and DZC shows good compliance but brings no obvious adver     

Effect of volatile oil of amomum on expressions of platelet activating factor and mastocarcinoma-related peptide in the gastric membrane of chronic gastritis patients with helicobacter-pylori infection

Objective： To observe the effect of volatile oil of amomum （VOA） on the expressions of mastocarcinoma-related peptide （PS2） and platelet activating factor （PAF） in helicobacter pylori- associated gastritis （HPG） and to analyze its potential mechanism. Methods： Eighty patients with HPG were randomly assigned to two groups, 42 patients in the treated group treated with 0.5 mL VOA, thrice per day; and the 38 patients in the control group receiving Western tertiary medicinal treatment. Gastroscopic picture and helicobacter pylori （HP） infection （by quick urease and Warthin- Starry stain） of the gastro-membrane, expressions of PS2 and PAF （by immunohistochemical assay and Western blotting） as well as the contents of aminohexose and phospholipid （by Neuhaus method） in the gastric membrane of all patients were detected before treatment and 4 weeks after treatment. The clinical efficacy in the two groups was compared. Results： The total effective rate in the treated group was 88.1%, which was significantly higher than that in the control group （78.9%, P〈0.05）. After treatment, in the treated group, gastric membranous contents of aminohexose and phospholipid was increased, expression of PS2 elevated but that of PAF lowered, all showing significant difference as compared with those in the control group （P〈0.01）. In the control group, the expressions of PS2 and PAF changed insignificantly. The radical eliminating rate of HP in the treated group and the control group was insignificantly different between them （76.1% vs. 65.8%, P 〉 0.05）. Conclusion： The mechanism of VOA for anti-gastritis might be related with its action in increasing the expression of PS2 and decreasing the expression of PAF, and thus regulating the hydrophobicity of the gastric membrane.     

Effect of Shengmai Injection (生脉注射液) on cardiac function and inflammatory reaction in patients with acute coronary syndrome

Objective： To confirm the effect of Shengmai Injection （生脉注射液, SMI） in improving cardiac function in patients with acute coronary syndrome （ACS） and to explore its influence on inflammatory reaction in patients. Methods： Ninety ACS patients were randomized into two groups, the control group treated with conventional therapy and the SMI group treated with SMI. The patients＇ cardiac function was noted and the content of high sensitive C-reactive protein （hs-CRP） in venous blood was measured before treatment and 1 week and 3 weeks after treatment, so as to observe and compare their changes between the two groups. Results： The cardiac output, stroke volume and ejection fraction in the SMI group after 3 weeks of treatment were all higher than those in the control group （P〈0.05）. The serum content of hs-CRP was reduced in both groups （P〈0.05）, but the reduction in the SMI group was more significant than that in the control group （P〈0.05）. Conclusion： SMI could improve the cardiac function and further inhibit the inflammatory reaction in patients with ACS.     

Effect of Yitangning Granule on Glycometabolism and Urinary Micro Albumin of Diabetes B Patients

One hundred and twenty patients with diabetes B that belong to the type of kidney deficiency andblood stasis were randomly divided into a treatment group treated with Yitangning Granule ( 益糖宁颗粒), a control group A treated with Jiangtangshu Capsule (降糖舒胶囊) and a control group B treated with Glurenorm Tablet (糖适平片). A better total effective rate was found in the treatment group, as compared with the two control groups, but there was no obvious difference. However, the treatment group was superior to the two control groups (P＜0.05 or P＜0.01) in the reduction of blood sugar and urinary micro albumin. It indicates that Yitangning Granule can improve the clinical symptoms and glycometabolism in patients with diabetes B and has a reverse effect on early diabetic nephropathy (DN).     

Clinical study of trilogy detoxicating therapy combined with routine Western medicine on patients with chronic renal failure

Objective： To investigate the mechanism of Trilogy Detoxicating Therapy in treating patients with chronic renal failure （CRF）. Methods： A total of 142 patients were assigned to the Trilogy Detoxicating Therapy group （the treatment group, 82 patients） and the Western medicine treatment group （the control group, 60 patients）. All of the patients were treated with NovoNorm 1 mg and metformin hydrochloride tablets 0.15 g thrice per day for lowering the blood glucose, as well as Perindopril 4 mg twice daily for lowering blood pressure, recombinant human erythropoietin 2 000 U and a hypodermic injection thrice a week for rectifying anemia, 30 days as one course of treatment, and all patients were treated for two courses. Patients in the treatment group were treated with the Trilogy Detoxicating Therapy [dispersing the five-zang （脏） organs, expelling toxins through colonic dialysis and skin dialysis fumigation] in addition to the aforementioned drugs. Parameters observed and recorded in the study included renal function [serum creatinine （SCr）, blood urea nitrogen （BUN）], blood lipids [triglyceride （TG）, total cholesterol （TC）, low-density lipoprotein C （LDL-C）, high-density lipoprotein C （HDL-C）], plasma total protein （TP）, hemoglobin （Hb）, serum interleukin-6 （IL-6）, and tumor necrosis factor-α （TNF-α） before and after the treatment. Results： After two courses of treatment, the levels of SCr, BUN, TG, TC, LDL-C, serum IL-6 and TNF-α decreased significantly, meanwhile HDL-C increased in the treatment group （P〈0.05 or P〈0.01）. In contrast, no obvious changes of the above mentioned items occurred in the control group. In both groups, the levels of TP and Hb were significantly elevated （P〈0.05 or P〈0.01）, but the changes were more obvious in the treatment group （P〈0.01）. Conclusion： Trilogy Detoxicating Therapy played a therapeutic role on patients with CRF possibly through lowering the levels of blood lipids, serum IL-6 and TNF- α     

Effects of Rebixiao Granules(热痹消颗粒剂) on Blood Uric Acid in Patients with Repeatedly Attacking Acute Gouty Arthritis

Objective:To observe the clinical effect of Rebixiao granule (热痹消颗粒剂, RBXG) in treating repeatedly attacking acute gouty arthritis and through experimental study on blood uric acid to explore RBXG's therapeutic mechanism. Methods: Ninety repeatedly attacking acute gouty arthritis patients were divided into the treated group (n= 60) and control group (n = 30). The treated group was treated with RBXG, and the control group was treated with Futalin tablets (diclofenac sodium). The baseline treatment including good rest, Iow purine diet, sufficient water drinking and urine alkalization, etc. was then given to both groups. Hypoxanthine 600 mg/kg and niacin 100 mg/kg was applied to hyperuricemic mice by gastrogavage to establish the animal models. Results: The clinical effective rate of the treated group was 95.0% and that of the control 90.0 %. Good therapeutic effects were won, insignificant difference (P＞0.05)was shown between the two groups. However, the cure rate of the treated group was 26.7% while that of the control group was 10.0%, with significant difference (P＜0.01) shown between them. The treated group had its blood uric acid lowered, which was significantly different (P＜0.05) from that of the control group. The animal experiment indicated that all the three groups treated with different dosages of RBXG, as well as the Ash bark and Smilax glabra rhizome groups had their blood uric acid content reduced in the hyperuricemic mice. Conclusion: RBXG has a quicker initiation and better treatment effects than sole anti-inflammatory and analgesic agents on the treatment of repeatedly attacking acute gouty arthritis, showing no obvious toxic or adverse reactions and therefore good for long-term administration and likely to be a safe TCM preparation to control the symptoms and reduce the onsets of repeatedly attacking of acute gouty arthritis. The animal experiment shows that both the compound preparation and part of the single ingredients in the recipe have the function of reducing blood uric acid. However, the compound recipe has better therapeutic effects, proving to be superior to single drugs.     

Regulatory effect of Langchuang serial recipes on T-lymphocyte subsets Th and Tc in patients with systemic lupus erythematosus

Objective： To study the principle of clearing Fei （肺）, cooling blood, and detoxification as well as nourishing yin and moisening Fei （abbr. as CCD-NM） in regulating the levels of peripheral T-lymphocyte subsets Th and Tc cells to explore its mechanism for lowering the incidence of infection in patients with systemic lupus erythematosus iSLE）. Methods： Sixty SLE patients without complicated infection were assigned to the treatment group and the control group, 30 in each group. The control group was treated with Western medicine alone, while the treatment group was treated with the same program of Western medicine, but additionally administered with either Langchuang No.1 （狼疮 Ⅰ号） or 2 （狼疮 Ⅱ 号）, serial concerted Chinese recipes, applied respectively in patients in the active stage or in the resting stage. The total time of treatment for both groups was 1 year. Further, a healthy control group was set up with 20 healthy subjects. The expressions of Thl, Th2, and Tcl and Tc2 cells in peripheral blood were detected and compared with those in the healthy control group. Results： （1） As compared with the healthy control group, ratios of Thl/Th2 and Tcl/Tc2 in SLE patients, whether complicated with infection or not, were significantly lower （P〈0.05 or P〈0.01）. （2） Comparison between patients with complications and those uncomplicated with infection showed that the two ratios and Thl expression were lower and Tc2 was higher in the former than those in the latter （all P〈0.05）. （3） Ratios of Thl/Th2 and Tcl/Tc2 increased after treatment in patients of both the treatment group and the control group （P〈0.05 and P〈0.01）, but the changes in the treatment group were more significant （P〈0.05）. Conclusion： The principle of CCD-NM could regulate the Th and Tc subsets toward equilibrium in SLE patients, which might be one of the mechanisms of action for alleviating complicated infection.     

Effects of Quyu Xiaoban Capsule(祛瘀消斑胶囊) on Vascular Endothelial Function in Patients with Atherosclerosis

Objective: To evaluate the therapeutic effects of Quyu Xiaoban Capsule (祛瘀消斑胶囊 ,QYXBC) on endothelial dependent vascular relaxation (EDVR) function in patients with atherosclerosis (AS)with ultrasonic technique. Methods: Tested were the endothelial function and blood lipids of 42 patients with AS in the treated group and 30 healthy volunteers in the control group. And re-examination of these parameters was carried out on the AS patients after they had been treated with QYXBC for 10 months. Results: Before treatment, the reactive hyperemia induced changes in artery diameter in the treated group was significantly lower than that in the control group (P＜0.01), while insignificant difference was found between the two groups in response to nitroglycerin. In the treated group after treatment, with D%-R improved significantly (P＜0.01), total cholesterol (TC), triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C)decreased by 16.3%, 5.6%, 10.2% respectively and high-density lipoprotein cholesterol (HDL-C) increased by 7.5%. EDVR was correlated negatively with the serum TC, LDL-C concentrations and the baseline brachial diameter (D0) (r = -0.41, -0.66, -0.59, respectively, all P＜0.01), but correlated positively with HDL-C (r = 0.62, P＜0.05). The ameliorative extent of EDVR was correlated positively to the decreased magnitude of TC and LDL-C concentrations ( r = 0.67,0.59, both P＜0.01 ). Conclusion: QYXBC can lower the level of blood lipids and improve significantly EDVR function.     

苯溴马隆结合威草胶囊治疗痛风的临床疗效

目的:研究中西医结合对痛风的治疗作用。方法:将160例痛风患者分为2组。治疗组:中西医结合,苯溴马隆片50mg/d,威草胶囊2粒/次,3次/d;对照组:苯溴马隆片50mg/d,1次。结果:①治疗组与对照组总有效率分别为95%、70%,两组有统计学意义(P<0.05)。②治疗组血β2-M明显下降(P<0.01),对照组无变化(P>0.05),治疗组血红蛋白较治疗前明显改善(P<0.01),两组有明显统计学意义(P<0.01),24h尿蛋白治疗组治疗后有显著改善(P<0.01),对照组无统计学意义(P>0.05),两组均能改善pH值(P<0.01)。组间比较无统计学意义(P>0.05)。③两组均能降低血尿酸,但治疗组更为明显(P<0.01)。④对BUN、Scr、Ccr,血脂治疗组治疗前后有显著改善(P<0.01),对照组无变化(P>0.05),两组比较有明显统计学意义。结论:中西医结合能显著降低血尿酸及血脂,改善肾功能,减少蛋白尿。     

涤浊汤联合中药足浴治疗脾虚湿阻型慢性痛风临床观察

目的:观察涤浊汤联合中药足浴治疗脾虚湿阻型慢性痛风的临床疗效。方法:将72例慢性痛风患者随机分为研究组与对照组各36例,对照组给予非布司他片+碳酸氢钠片治疗,研究组在对照组的基础上给予内服涤浊汤+中药足浴治疗。比较两组患者治疗前后的中医证候积分、疼痛视觉模拟评分(VAS)及血尿酸(BUA)、红细胞沉降率(ESR)、高敏C反应蛋白(hs-CRP)水平,评定临床疗效并观察痛风急性发作情况,随访2个月的复发情况。结果:研究组的临床总有效率88.89%明显优于对照组69.44%(P<0.05);两组患者治疗后4周、8周和12周的VAS评分均较治疗前显著降低,且研究组明显低于对照组(P<0.05);研究组治疗后的BUA、ESR及hs-CRP水平显著低于对照组(P<0.05);研究组的痛风急性发作率11.11%,明显低于对照组33.33%(P<0.05);随访2个月,研究组的痛风复发率16.67%,明显低于对照组38.89%(P<0.05);两组在治疗过程中均未出现明显不良反应及并发症。结论:涤浊法联合中药足浴治疗脾虚湿阻型慢性痛风患者的疗效显著,能有效改善临床症状,促进BUA排泄,减轻患者疼痛,减少痛风的急性发作及复发率,且安全可靠,值得临床进一步研究探讨。     

风湿Ⅱ号合剂预防原发性痛风复发的临床研究

目的:观察"风湿Ⅱ号合剂"预防原发性痛风复发的临床疗效.方法:将原发性痛风患者74例随机分为治疗组38例与对照组36例.治疗组给予"风湿Ⅱ号合剂"口服治疗3个月,对照组单纯以饮食控制.比较两组的痛风复发率及血尿酸、血脂、肝肾功能的变化.结果:治疗组痛风复发3例,复发率7.89%;对照组痛风复发12例,复发率33.33%.两组比较,P<0.05.治疗组血尿酸、血脂较对照组为低(P<0.05),而且治疗组经过3个月的"风湿Ⅱ号合剂"治疗,肝肾功能均正常.结论:"风湿Ⅱ号合剂"具有预防原发性痛风复发及降低血尿酸、血脂的作用,无明显不良反应.     

复方玄驹胶囊对前列腺增生术后患者性功能的影响

目的探讨复方玄驹胶囊对前列腺增生术后患者性功能的影响。方法选择2018年8月至2019年8月本院行前列腺增生术治疗患者83例,采用随机数字表法分为两组,所有患者均接受经尿道前列腺等离子双极电切除术(Transurethral bipolar plasmakinetic prostatectomy,TUPKRP)治疗,对照组术后给予保列治治疗,观察组在其基础上给予复方玄驹胶囊治疗。观察两组治疗前后的血清肌酐水平、国际勃起功能(International index of erectile function,IIEF-5)、早泄诊断评分(Chinese Index of premature ejaculation,CIPE)及早泄诊断工具(Premature ejaculation diagnostic tool,PEDT)量表评分,并比较两组患者生活质量(Short-form 36 questionnaire,SF-36)评分。结果治疗前两组患者血清肌酐水平比较,差异无统计学意义(P0.05);观察组治疗后的血清肌酐水平明显低于对照组(P0.05);两组治疗前IIEF-5、CIPE、PEDT评分比较,差异无统计学意义(P0.05);两组治疗后IIEF-5、CIPE、PEDT评分均高于治疗前,且观察组高于对照组(P0.05);两组治疗后生理功能、生理职能、总体健康、活力、社会功能、情感职能、精神健康均高于治疗前,躯体疼痛评分低于治疗前,且观察组上述评分均优于对照组(P均0.05)。结论复方玄驹胶囊用于前列腺增生术后患者的治疗中能够改善患者的性功能,降低血清肌酐水平,提高生活质量。     

补肾健脾降浊汤联合促红细胞生成素治疗维持性血液透析患者肾性贫血的疗效观察

目的 探讨补肾健脾降浊汤联合促红细胞生成素（erythropoietin,EPO）治疗维持性血液透析（maintenance hemodialysis,MHD）患者合并肾性贫血的临床疗效。方法 选择2020年9月至2022年6月浙江萧山医院肾内科60例MHD患者,采用随机数字表法分为治疗组和对照组,每组各30例。对照组皮下注射EPO注射液及口服铁剂、叶酸等一般治疗,治疗组在对照组的基础上联合补肾健脾降浊汤治疗,两组均连续治疗8周,比较两组患者的红细胞（red blood cell,RBC）、血红蛋白（hemoglobin,Hb）、白蛋白（albumin,ALB）、血清铁蛋白（serum ferritin,SF）、转铁蛋白饱和度（transferrin saturation,TSAT）、C反应蛋白（C-reaction protein,CRP）及血清钾（serum potassium,K）、肌酐（creatinine,Cr）、尿素氮（blood urea nitrogen,BUN）、尿酸（uric acid,UA）的水平。结果 治疗后,治疗组的RBC、Hb水平较治疗前升高,且高于对照组（P<0.05）;治疗组的血清ALB较治疗前显著升高（P<0.01）,对照组治疗前后比较差异无统计学意义（P>0.05）;治疗后治疗组的CRP较治疗前显著降低（P<0.05）,对照组治疗前后比较差异无统计学意义（P>0.05）;治疗组的SF、TSAT治疗前后比较,差异无统计学意义（P>0.05）,而对照组治疗后SF显著降低（P<0.05）,TSAT治疗前后无统计学意义（P>0.05）。两组患者的Cr、BUN、UA及血K水平组间及治疗前后比较,差异无统计学意义（P>0.05）。结论 补肾健脾降浊汤联合EPO注射液能较好地纠正MHD患者的肾性贫血,改善营养状况,减轻微炎症反应,缓解因EPO注射液治疗引起的贮存铁消耗。     

丹蛭降糖胶囊对2型糖尿病合并大血管病变患者糖脂代谢及生活质量的影响

目的 观察丹蛭降糖胶囊对2型糖尿病合并大血管病变患者糖脂代谢及生活质量的影响。方法 选取2型糖尿病合并大血管病变患者50例,随机分为对照组和治疗组各25例,对照组给予西药常规治疗,治疗组加服丹蛭降糖胶囊,治疗4周,检测并对比干预前后两组患者血清空腹血糖(fasting blood glucose,FPG)、餐后2小时血糖(2-hour postprandial blood glucose,2hPG)、稳态评估模型胰岛素抵抗指数(homeostasis model assessment of insulin resistance,HOMA-IR)、三酰甘油(triacylglycerol,TG)、总胆固醇(total cholesterol,TC)、高密度脂蛋白胆固醇(high density lipoprotein cholesterol,HDL)、低密度脂蛋白胆固醇(low density lipoprotein cholesterol,LDL)水平的变化情况;采用生存质量特异性量表(diabetes specific quality of life,DSQL)评价生存质量,根据临床症状和血糖改善情况综合判断疗效。结果 与治疗前比较,两组患者治疗后血清FPG、2hPG、TG、LDL水平均显著降低（P＜0.05）,HDL水平显著升高（P＜0.05),且治疗组治疗后血清TC水平显著降低（P＜0.05）,对照组患者治疗后血清TC水平变化无统计学意义（P＞0.05）;与对照组比较,治疗组患者血清2hPG、TC水平下降更显著(P＜0.05),HDL水平升高更显著（P＜0.05);与对照组比较,治疗组患者生理功能评分降低程度显著大于对照组（P＜0.05）;治疗组临床疗效优于对照组（P＜0.05）。结论 丹蛭降糖胶囊能显著降低2型糖尿病合并大血管病患者血清血糖血脂水平,有效拮抗患者胰岛素抵抗和血液脂毒性,提高患者生活质量和临床疗效。     

血脂康对单纯性脂肪肝患者血脂血糖及胰岛素的影响

目的探讨血脂康对单纯性脂肪肝患者血脂、血糖及胰岛素的影响。方法单纯性脂肪肝患者68例,随机分为对照组和治疗组。对照组给予改善生活方式、控制体重、维生素及保肝药物等常规治疗;治疗组在常规治疗基础上加用血脂康治疗。两组患者于治疗前及治疗3个月、6个月后分别检测血脂、空腹血糖(FPG)、餐后2 h血糖、空腹胰岛素(FIns)、餐后2 h胰岛素,并计算胰岛素抵抗指数(HOMA-IR)和胰岛素敏感指数(ISI)。结果治疗组与对照组治疗3个月TG均降低、HDL-C均升高,两组比较有显著差异(P<0.05);治疗6个月TG、TC、LDL-C、FFA均降低,HDL-C均升高,两组比较有显著差异(P<0.05或P<0.01)。治疗组与对照组治疗3个月HOMA-IR均降低,两组比较有显著差异(P<0.05);治疗6个月空腹血糖、餐后2 h胰岛素、HOMA-IR均降低,ISI升高,两组比较有显著差异(P<0.05或P<0.01)。结论血脂康不仅可以改善单纯性脂肪肝患者的血脂和血糖,同时能够改善患者的胰岛素抵抗,并与治疗时间相关。     

黄芪注射液联合高通量血液透析对尿毒症患者肾功能和血清微RNA-155、白细胞介素-17、超敏C反应蛋白水平的影响

目的 探讨黄芪注射液联合高通量血液透析(HFHD)对尿毒症患者肾功能及血清微RNA-155(miR-155)、白细胞介素-17(IL-17)、超敏C反应蛋白(hs-CRP)水平的影响。方法 选择2016年12月至2019年12月长安医院收治的156例尿毒症患者为研究对象,根据治疗方法将患者分为观察组(n=86)和对照组(n=70)。2组患者均给予积极治疗原发疾病、纠正贫血及进食低盐、富含优质蛋白质类食物等常规治疗措施;在常规治疗基础上,对照组患者给予HFHD治疗,观察组患者给予黄芪注射液和HFHD联合治疗。治疗前及治疗3、6个月,测量患者舒张压(DBP)和收缩压(SBP),检测患者血尿素氮(BUN)、血肌酐(SCr)、前白蛋白(PA)、白蛋白(Alb)、血红蛋白(Hb)、IL-17和hs-CRP及miR-155水平,并测量患者24 h尿量和24 h尿蛋白。治疗6个月后评估2组患者临床疗效。结果 治疗前2组患者DBP、SBP、SCr、BUN水平及24 h尿蛋白、24 h尿量比较差异无统计学意义(P>0.05),2组患者治疗3、6个月后DBP、SBP、SCr、BUN水平及24 h尿蛋...     

中医综合治疗早中期慢性肾功能衰竭脾肾气虚证疗效观察

目的 观察中医综合治疗早中期慢性肾功能衰竭（chronic renal failure,CRF）脾肾气虚证临床疗效。方法 将60例CRF患者随机分为对照组和治疗组,每组30例。两组均给予西医常规治疗,治疗组患者在此基础上口服补肾健脾方配合擦背辅助治疗,对照组患者口服百令胶囊,两组疗程均为8周。比较两组患者治疗前后估算的肾小球滤过率（estimated glomerular filtration rate,eGFR）、血尿素氮（blood urea nitrogen,BUN）、血清肌酐（serum creatinine,SCr）、血红蛋白（hemoglobin,Hb）、白蛋白（albumin,ALB）的变化,评价两组临床疗效及症状改善情况。结果 与治疗前比较,两组患者治疗后SCr、BUN水平均显著下降（P<0.05）,eGFR、ALB、Hb水平均显著升高（P<0.05）。治疗组患者治疗后SCr、BUN水平下降程度以及eGFR、ALB、Hb水平上升程度较对照组更为显著（P<0.05）。两组中医证候疗效分布、临床疗效分布比较,差异均有统计学意义（P<0.05）。结论 西医常规疗法联合中医综合治疗可以显著改善CRF患者的肾功能,提高患者生存质量。